Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101 (NCT06545162) | Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. | 2024-12-04 |
| Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus (NCT06532578) | Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. | 2024-08-13 |
Track Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.